Gaëtan Ligat

Associate Professor

Université Paul Sabatier

France

Research Interests

Explore related searches

Professors in France Professors in Microbiology Microbiology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gaëtan Ligat is an Associate Professor at Paul Sabatier University in France. His research focuses on viral infections, particularly human cytomegalovirus and hepatitis B virus, with recent articles highlighting therapeutic strategies and host interactions. He has contributed to advancing the understanding of antiviral agents and the development of prophylactic vaccines.

Articles (13)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Maxime Pichon

Associate Professor

Centre Hospitalier Universitaire Vaudois

FRANCE

View details

Eloi Verrier

University of Strasbourg

FRANCE

View details

Cécile MALNOU

Assistant professor

INSERM

FRANCE

View details

Naoto Fujiwara

Mie University Hospital

JAPAN

View details

Michael Nassal

Professor of Medical Molecular Biology (Emeritus since 10/2020)

University Medical Center Freiburg

GERMANY

View details

Thomas F. Baumert

Professor or Medicine

University of Strasbourg

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gaëtan Ligat

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

First evidence of efficacy of peptides targeting the pUL56-pUL89 interaction domain of the human cytomegalovirus terminase complex

Challenges and advances in the management of HCMV infections

Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target

The Yin and the Yang of extracellular vesicles during viral infections

Editorial: Recent highlights in the development of therapeutic antiviral strategies.

Bringing clinical and fundamental young microbiologists together

Capsid Assembly Modulators as Antiviral Agents against HBV: Molecular Mechanisms and Clinical Perspectives

Hepatitis B virus–host interactions and novel targets for viral cure

New Insights into Human Cytomegalovirus pUL52 Structure

Towards a Prophylactic Vaccine for the Prevention of HCMV Infection

Structures and Divergent Mechanisms in Capsid Maturation and Stabilization Following Genome Packaging of Human Cytomegalovirus and Herpesviruses

Targeting Viral cccDNA for Cure of Chronic Hepatitis B

The terminase complex, a relevant target for the treatment of HCMV infection.

Collaborators (6)

Maxime Pichon

Eloi Verrier

Cécile MALNOU

Naoto Fujiwara

Michael Nassal

Thomas F. Baumert

Make your next move.